SCHEMBL25870846

SCHEMBL25870846

CCC(=O)N1CCC2(CCN(C)CC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
HIF1A Q16665 1/20 0.43
OPRM1 P35372 1/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPK1 P28482 1/20 0.42
BLM P54132 1/20 0.40
EPHX2 P34913 2/20 0.38
USP2 O75604 1/20 0.38
KMT2A Q03164 1/20 0.37
HTR1A P08908 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
CHRNB3 Q05901 1/20 0.37
CHRNA6 Q15825 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15998851 0.90 ALDH1A1 (0.47) CYP1A2OPRM1ALDH1A1MAPK1BLM
SCHEMBL25876408 0.86 ALDH1A1 (0.50) CYP1A2OPRM1ALDH1A1EPHX2USP2
SCHEMBL21480105 0.86 ALDH1A1 (0.45) CYP1A2OPRM1ALDH1A1BLMEPHX2
SCHEMBL25561799 0.85 OPRM1 (0.45) CYP1A2HIF1AOPRM1ALDH1A1MAPK1
SCHEMBL15998880 0.83 OPRM1 (0.46) OPRM1ALDH1A1USP2CYP3A4CYP2D6
SCHEMBL25703446 0.82 ALDH1A1 (0.53) CYP1A2HIF1AOPRM1ALDH1A1MAPK1
SCHEMBL26854526 0.81 ALDH1A1 (0.48) OPRM1ALDH1A1BLMEPHX2USP2
SCHEMBL26868241 0.81 CYP1A2 (0.54) CYP1A2ALDH1A1CHRNB2CHRNA3CHRNA4
SCHEMBL802314 0.81 CYP1A2 (0.54) CYP1A2ALDH1A1BLMKMT2AHTR1A
SCHEMBL21765702 0.79 OPRM1 (0.53) CYP1A2OPRM1ALDH1A1MAPK1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116920-A1 PENTA- FUSED HEXA-HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE 杭州多域生物技术有限公司 2023-06-29 WO disclosed